Drug intelligence / Profile preview

Ocuvers Lipostamin

Development stage
Unknown
Lead developer
Innomedis
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

Ocuvers Lipostamin is a liposomal spray developed by Innomedis AG for the treatment of dry eye syndrome (DES). It is formulated with a phospholipid complex and a blend of natural plant extracts, including *Capparis spinosa* (caper), *Helichrysum italicum* (everlasting), *Euphrasia officinalis* (eyebright), and *Glycyrrhiza glabra* (licorice). The spray is designed to stabilize the lipid layer of the tear film, which is often deficient in patients with dry eye. Clinical studies suggest that Ocuvers Lipostamin effectively improves subjective comfort, tear break-up time (TBUT), and tear meniscus height, while also reducing conjunctival redness, potentially due to the anti-inflammatory and antioxidant properties of its botanical components. It is noted for having a better tolerability profile, including less initial burning sensation and a less fatty smell, compared to earlier generations of liposomal sprays.

Brand names
Ocuvers Lipostamin
Other names
OL

Beyond the preview

Go deeper on Ocuvers Lipostamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocuvers Lipostamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call